Orchid Pharma's Total Assets for the quarter that ended in Mar. 2024 was ₹15,539 Mil.
During the past 12 months, Orchid Pharma's average Total Assets Growth Rate was 7.10% per year.
During the past 3 years, the average Total Assets Growth Rate was 2.10% per year.
During the past 5 years, the average Total Assets Growth Rate was -11.60% per year.
During the past 13 years, Orchid Pharma's highest 3-Year average Total Assets Growth Rate was 25.60%. The lowest was -26.20%. And the median was -2.40%.
The historical data trend for Orchid Pharma's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Orchid Pharma's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orchid Pharma (NSE:ORCHPHARMA) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Orchid Pharma's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Orchid Pharma Total Assets Related Terms
Thank you for viewing the detailed overview of Orchid Pharma's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Orchid Pharma (NSE:ORCHPHARMA) Business Description
Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Pharmaceutical Products. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:ORCHPHARMA has been successfully added to your 